Table 4 Prognostic factors toward distant metastasis (n = 45)

Age^#

54.67

12.12

56.88

12.71

0.568

Gender

Male

5

41.67

15

45.45

0.821

Female

7

58.33

18

54.55

Cancer Site

Splenic Flexure

1

8.33

1

3.03

0.578

Descending colon

2

16.67

7

21.21

Sigmoid

7

58.33

23

69.70

Rectosigmoid

2

16.67

2

6.06

Upfront surgery

7

58.33

21

63.64

0.764

SEMS

5

41.67

12

36.36

T stage

2

1

8.33

4

12.12

0.864

3

9

75.00

22

66.67

4

2

16.67

7

21.21

TNM stage

Stage 1

0

0.00

3

9.09

0.384

Stage 2

2

16.67

15

45.45

0.076

Stage 3

10

83.33

15

45.45

0.025*

Positive lymph node

10

83.33

15

45.45

0.025*

< 12 lymph node dissected

1

8.33

2

6.06

0.616

Positive Lymph node^#

2.25

3.05

1.33

2.33

0.109

Lymph node dissected^#

21.42

6.93

18.85

7.61

0.122

Perineural invasion

4

33.33

3

9.09

0.069

Lymphovascular invasion

3

25.00

4

12.12

0.268

Mucin production

1

8.33

3

9.09

0.714

SEMS to surgery in days^#

11.40

7.27

14.75

11.19

0.879

SEMS to surgery > 14 days

2

16.67

4

12.12

0.605

Adjuvant chemotherapy

11

91.67

30

90.91

0.714

Approach of surgery

Laparoscopic

9

75.00

29

87.88

0.268

Converted to open

1

8.33

3

9.09

0.714

Open

3

25.00

4

12.12

0.268

Type of surgery

Total colectomy

1

8.33

1

3.03

0.467

Left hemicolectomy

4

33.33

10

30.30

0.558

Anterior resection

7

58.33

22

66.67

0.606